We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+4.63%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+763.65%
AUM
$77.1B
AUM Growth
-$1.68B
(-2.1%)
Cap. Flow
-$2.68B
Cap. Flow
% of AUM
-3.48%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
3,716
New
704
Increased
979
Reduced
1,056
Closed
911
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.75% |
| 2 | Industrials | 9.36% |
| 3 | Consumer Discretionary | 8.52% |
| 4 | Healthcare | 7.75% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
CALL
Affirm
AFRM
$23.5B
| $2.82M | ﹤0.01% |
61,500
-61,300
| -50% | -$3.54M |
|
1552
PUT
Vertex Pharmaceuticals
VRTX
$123B
| $2.81M | ﹤0.01% |
6,300
-800
| -11% | -$373K |
|
|
1553
PUT
Affirm
AFRM
$23.5B
| $2.81M | ﹤0.01% |
61,300
-25,900
| -30% | -$1.5M |
|
1554
Amgen
AMGN
$209B
| $2.81M | ﹤0.01% |
7,980
-5,688
| -42% | -$2.03M |
|
1555
EOG Resources
EOG
$77.7B
| $2.8M | ﹤0.01% |
19,379
-451
| -2% | -$54.7K |
|
1556
CALL
WIX.com
WIX
$2.56B
| $2.8M | ﹤0.01% |
+31,100
| New | +$2.6M |
|
1557
Spyre Therapeutics
SYRE
$8.5B
| $2.8M | ﹤0.01% |
55,477
-17,988
| -24% | -$678K |
|
|
GAP
1558
CALL
The Gap Inc
GAP
$7.3B
| $2.8M | ﹤0.01% |
115,500
-667,600
| -85% | -$17.7M |
|
1559
Constellation Energy
CEG
$92.1B
| $2.78M | ﹤0.01% |
9,969
+5,296
| +113% | +$1.61M |
|
1560
Blackstone
BX
$104B
| $2.78M | ﹤0.01% |
24,172
-859,313
| -97% | -$112M |
|
1561
Apogee Enterprises
APOG
$833M
| $2.78M | ﹤0.01% |
82,857
+62,086
| +299% | +$2.3M |
|
1562
Cousins Properties
CUZ
$5.31B
| $2.77M | ﹤0.01% |
122,755
-222,153
| -64% | -$5.39M |
|
1563
PUT
Intuit
INTU
$91.1B
| $2.77M | ﹤0.01% |
6,400
-8,600
| -57% | -$4.1M |
|
1564
Gilead Sciences
GILD
$165B
| $2.76M | ﹤0.01% |
19,774
-4,753
| -19% | -$666K |
|
1565
Liquidia Corp
LQDA
$7.72B
| $2.75M | ﹤0.01% |
72,895
+15,225
| +26% | +$565K |
|
1566
PUT
Cadence Design Systems
CDNS
$91.6B
| $2.75M | ﹤0.01% |
9,900
+6,700
| +209% | +$2M |
|
1567
Atkore
ATKR
$2.41B
| $2.75M | ﹤0.01% |
46,663
-21,760
| -32% | -$1.41M |
|
1568
Phillips 66
PSX
$82.9B
| $2.75M | ﹤0.01% |
15,075
+5,245
| +53% | +$822K |
|
|
VIA
1569
Via Transportation Inc
VIA
$1.68B
| $2.75M | ﹤0.01% |
+183,072
| New | +$3.65M |
|
1570
PUT
Datadog
DDOG
$94B
| $2.74M | ﹤0.01% |
23,200
-106,000
| -82% | -$13.1M |
|
1571
Global X US Infrastructure Development ETF
PAVE
$13.5B
| $2.73M | ﹤0.01% |
+53,800
| New | +$2.8M |
|
|
GLIBK
1572
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$932M
| $2.73M | ﹤0.01% |
73,272
+56,231
| +330% | +$2.13M |
|
1573
Ibotta
IBTA
$618M
| $2.72M | ﹤0.01% |
90,870
+42,095
| +86% | +$984K |
|
|
FITB
1574
Fifth Third Bancorp
FITB
$51.3B
| $2.72M | ﹤0.01% |
58,605
+4,479
| +8% | +$221K |
|
1575
CALL
Ondas Inc
ONDS
$3.87B
| $2.71M | ﹤0.01% |
+300,000
| New | +$3.26M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Balyasny Asset Management held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Balyasny Asset Management withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Balyasny Asset Management opened a new position in Silicon Laboratories worth $257M.
- Balyasny Asset Management's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Balyasny Asset Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Balyasny Asset Management's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Balyasny Asset Management fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Balyasny Asset Management's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Balyasny Asset Management opened 704 new positions and closed 911 in Q1 2026.
- Balyasny Asset Management's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.